E-LIB Suche - Ergebnisse für: Bressler, B

1

P789 Impact of risk factors for Janus kinase inhibitor use ..:

Siegmund, B ; Kuehbacher, T ; Armuzzi, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1471-i1473 , 2024

Link: https://doi.org/10.1093/..

2

DOP52 Guselkumab improves symptoms of fatigue in patients w..:

Dignass, A ; Panés, J ; Rubin, D T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i166-i167 , 2024

Link: https://doi.org/10.1093/..

3

P477 Performance of bowel preparation quality scales in pat..:

Solitano, V ; Siegel, C A ; Korzenik, J R...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i956-i957 , 2024

Link: https://doi.org/10.1093/..

4

A24 AN ULCERATIVE COLITIS-ISOLATED PATHOBIONT CAN DEGRADE M..:

Gilliland, A ; Chen, Y ; Tertigas, D...
Journal of the Canadian Association of Gastroenterology. 7 (2024) Supplement_1 - p. 13-14 , 2024

Link: https://doi.org/10.1093/..

5

P627 Real-world clinical effectiveness and safety of vedoli..:

Scharl, M ; Christensen, B ; Bressler, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1203-i1204 , 2024

Link: https://doi.org/10.1093/..

6

P954 Cumulative response to guselkumab through week 24 of i..:

Rubin, D ; Sands, B ; Lichtenstein, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1732-i1733 , 2024

Link: https://doi.org/10.1093/..

7

A239 MOTIVATIONS BEHIND CAM USE IN PATIENTS WITH CROHN'S DI..:

Klemm, N K ; Trasolini, R ; Bressler, B..
Journal of the Canadian Association of Gastroenterology. 7 (2024) Supplement_1 - p. 191-193 , 2024

Link: https://doi.org/10.1093/..

8

DOP46 Tofacitinib for hospitalized acute severe Ulcerative ..:

Narula, N ; Peerani, F ; Hansen, T...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i156-i156 , 2024

Link: https://doi.org/10.1093/..

9

A275 THE POTENTIAL MECHANISTIC ROLES OF SPHINGOLIPIDS IN HE..:

Xue, M ; Lee, S ; Neustaeter, A...
Journal of the Canadian Association of Gastroenterology. 7 (2024) Supplement_1 - p. 221-222 , 2024

Link: https://doi.org/10.1093/..

10

DOP49 Guselkumab improves health-related quality of life as..:

Panés, J ; Dignass, A ; Lichtenstein, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i161-i162 , 2024

Link: https://doi.org/10.1093/..

11

P1010 Guselkumab improves abdominal pain and bowel urgency ..:

Rubin, D ; Panés, J ; Feagan, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1825-i1826 , 2024

Link: https://doi.org/10.1093/..

12

A274 THE EFFECT OF DIETARY MODULATION ON FUNGAL AND VIRAL C..:

Buttar, J ; Kon, E ; Lawal, S...
Journal of the Canadian Association of Gastroenterology. 6 (2023) Supplement_1 - p. 88-89 , 2023

Link: https://doi.org/10.1093/..

13

A175 REAL-WORLD EXPERIENCE ON SWITCHING FROM ADALIMUMAB TO ..:

Bedi, H ; Rosenfeld, D ; Hoang, T...
Journal of the Canadian Association of Gastroenterology. 6 (2023) Supplement_1 - p. 19-20 , 2023

Link: https://doi.org/10.1093/..

14

P493 QUASAR Induction Study 1 Cumulative Response to Guselk..:

Peyrin-Biroulet, L ; Rubin, D ; Lichtenstein, G...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i624-i625 , 2023

Link: https://doi.org/10.1093/..

15

P752 Predictors of time to relapse upon ozanimod withdrawal..:

Vermeire, S ; Abraham, B ; Bressler, B...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i882-i884 , 2023

Link: https://doi.org/10.1093/..